BioRestorative Therapies, Inc. (BRTX) › Net IncomeBioRestorative Therapies, Inc. (BRTX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$1.20M2010: -$2.26M2011: -$4.07M2012: -$6.54M2013: -$5.75M2014: -$5.59M2015: -$7.92M2016: -$8.64M2017: -$9.44M2018: -$12.52M2019: -$14.65M2020: -$11.27M2021: -$44.30M2022: -$13.22M2023: -$10.42M2024: -$8.98M2025: -$14.24M-$14.24M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$14.24M-58.6%2024-$8.98M+13.8%2023-$10.42M+21.2%2022-$13.22M+70.2%2021-$44.30M-293.0%2020-$11.27M+23.0%2019-$14.65M-17.0%2018-$12.52M-32.5%2017-$9.44M-9.4%2016-$8.64M-9.0%2015-$7.92M-41.8%2014-$5.59M+2.8%2013-$5.75M+12.0%2012-$6.54M-60.5%2011-$4.07M-80.0%2010-$2.26M-89.1%2009-$1.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share